GSK
840 hedge funds and large institutions have $11.6B invested in GSK in 2024 Q4 according to their latest regulatory filings, with 107 funds opening new positions, 283 increasing their positions, 319 reducing their positions, and 149 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $12.7B → $11.6B (-$1.08B)
11% less repeat investments, than reductions
Existing positions increased: 283 | Existing positions reduced: 319
28% less first-time investments, than exits
New positions opened: 107 | Existing positions closed: 149
Holders
840
Holding in Top 10
12
Calls
$460M
Puts
$105M
Top Buyers
| 1 | +$805M | |
| 2 | +$352M | |
| 3 | +$197M | |
| 4 |
Goldman Sachs
New York
|
+$78.2M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$68.2M |
Top Sellers
| 1 | -$162M | |
| 2 | -$123M | |
| 3 | -$92.9M | |
| 4 |
HSBC Holdings
London,
United Kingdom
|
-$86M |
| 5 |
Morgan Stanley
New York
|
-$75.3M |